P02893 (CSP_PLAFA) Plasmodium falciparum
Circumsporozoite protein UniProtKBInterProInteractive Modelling
412 aa; Sequence (Fasta) ;
1 identical sequence: Plasmodium falciparum: Q5R2L8
Available Structures
33 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of Fab399 in complex with NPNA6 peptide from circumsporozoite protein |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of 1210 Fab in complex with circumsporozoite protein NANP5 |
Heteromer | 29×EDO; 5×PEG; | ||||
| Assess | ||||||
| Crystal structure of 1450 Fab in complex with circumsporozoite protein NANP5 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of Fab239 in complex with NPNA4 peptide from circumsporozoite protein |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.149 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m42.126 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.160 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.159 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.138 |
Heteromer | |||||
| Assess | ||||||
| Structure of PfCSP peptide 21 with human antibody CIS42 |
Heteromer | |||||
| Assess | ||||||
| Structure of PfCSP peptide 21 with human protective antibody CIS43 |
Heteromer | 4×SO4; 1×EDO; | ||||
| Assess | ||||||
| Structure of PfCSP peptide 25 with human antibody CIS42 |
Heteromer | 9×IPA; 26×NH4; 13×NA; | ||||
| Assess | ||||||
| Structure of PfCSP peptide 29 with human antibody CIS42 |
Heteromer | 1×NH4; | ||||
| Assess | ||||||
| Structure of PfCSP peptide 21 with antibody iGL-CIS43.D3 |
Heteromer | 1×MES; 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of Fab224 in complex with NPNA4 peptide from circumsporozoite protein |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of antibody 5D5 in complex with PfCSP N-terminal peptide |
Heteromer | 1×NAG; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of Fab317 complex |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of Fab366 in complex with NPNA3 peptide from circumsporozoite protein |
Heteromer | |||||
| Assess | ||||||
| Fab397 in complex with NPNA peptide |
Heteromer A8K008; Q8TCD0; | |||||
| Assess | ||||||
| Crystal structure of Fab399 in complex with NPNA3 peptide from circumsporozoite protein |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of chimeric H.2140 / K.1210 Fab in complex with circumsporozoite protein NANP3 |
Heteromer | 3×GOL; 1×PEG; | ||||
| Assess | ||||||
| Structure of PfCSP peptide 25 with human protective antibody CIS43 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of Fab311 complex |
Heteromer | 3×MES; 2×1PE; | ||||
| Assess | ||||||
| Structure of PfCSP peptide 20 with human antibody CIS42 |
Heteromer | |||||
| Assess | ||||||
| Structure of PfCSP peptide 20 with human protective antibody CIS43 |
Heteromer | |||||
| Assess | ||||||
| Structure of PfCSP peptide 29 with human protective antibody CIS43 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of the 580 germline antibody bound to circumsporozoite protein NANP 5-mer |
Heteromer | 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of Fab239 in complex with NPNA2 peptide from circumsporozoite protein |
Heteromer P19909; | |||||
| Assess | ||||||
| Crystal structure of Fab364 in complex with NPNA2 peptide from circumsporozoite protein |
Heteromer P19909; | |||||
| Assess | ||||||
| Crystal structure of Fab356 in complex with NPNA2 peptide from circumsporozoite protein |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of 663 Fab bound to circumsporozoite protein NANP 5-mer |
Heteromer | 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of Fab395 in complex with NPNA2 peptide from circumsporozoite protein |
Heteromer | |||||
| Assess | ||||||
| Structural and immunological analysis of circumsporozoite protein peptides: a further step in the i… | monomer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7rxp.1.C | monomer | 0.78 | 90.77 | |||
| Assess | ||||||